The influence of Bcl-2 expression on the suppression of apoptosis during the cultivation of an NS0 cell line expressing a chimeric antibody was investigated. Following selection of transfectants in medium containing G418, Western analysis revealed evidence of some up-regulation of endogenous Bcl-2 expression even in the control vector transfectants. Cultivation of the two cell lines in suspension batch cultures clearly demonstrated the enhanced robustness of the bcl-2 vector transfected cells. Suppression of apoptosis resulted in an approximately 20% increase in maximum viable cell number, and a doubling in culture duration compared to the control transfected cells. However, despite the significant affect on viability, Bcl-2 expression did not result in an increase in final antibody titre in comparison with the control cell line. Exposure of cells to various nutrient limited conditions further emphasised the influence of Bcl-2 on cell survival. After 3 days of exposure to serum, glucose, glutamate and asparagine deprivation, the viable cell number and viability were significantly higher in the bcl-2 transfected cell line. When control cells were deprived of all amino acids, there was a complete loss of viability and viable cell number within 3 days. By contrast, the bcl-2 transfected cell line retained greater than 75% of the initial viable cell number and about 70% viability. In response to exposure to 8 mM thymidine (a cytostatic agent) the control cell line underwent complete loss of viability and viable cell number after 6 days. This compared with 18 days for complete loss of viability in the bcl-2 transfected cell line. As under batch culture conditions, there was no difference between the two cell lines in final antibody titre, which indicated that MAb synthesis is limited by nutrient availability during the latter stages of culture in both cases. When fed batch cultures were carried out using a concentrated essential amino acid feed, the bcl-2 cell line exhibited a 60% increase in maximum viable cell number and a 50% increase in culture duration, when compared to the control cell line. Moreover, the bcl-2 cell line exhibited a greater than 40% increase in maximum antibody titre. (C) 2000 Elsevier Science B.V. All rights reserved.
Tey, B.T., Singh, R.P., Piredda, L., Piacentini, M., & Al-Rubeai, M. (2000). Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. JOURNAL OF BIOTECHNOLOGY, 79(2), 147-159.
|Tipologia:||Articolo su rivista|
|Citazione:||Tey, B.T., Singh, R.P., Piredda, L., Piacentini, M., & Al-Rubeai, M. (2000). Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures. JOURNAL OF BIOTECHNOLOGY, 79(2), 147-159.|
|Settore Scientifico Disciplinare:||Settore BIO/06|
|Revisione (peer review):||Sì, ma tipo non specificato|
|Digital Object Identifier (DOI):||http://dx.doi.org/10.1016/S0168-1656(00)00223-6|
|Stato di pubblicazione:||Pubblicato|
|Data di pubblicazione:||2000|
|Titolo:||Bcl-2 mediated suppression of apoptosis in myeloma NS0 cultures|
|Autori:||Tey, BT; Singh, RP; Piredda, L; Piacentini, M; Al-Rubeai, M|
|Appare nelle tipologie:||01 - Articolo su rivista|